Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)

Clinical trial NCT06939816 · TERMINATED

Trial details

NCT number: NCT06939816
Sponsor: Enyo Pharma
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Kidney Disease Stage 2 Chronic Kidney Disease Stage 3 Metabolic Dysfunction-Associated Steatohepatitis

Start date: 2025-07-01
Primary completion: 2025-12-22
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.